Compromised lipid homeostasis in Lal−/− mice, arising from impaired hepatic and intestinal lipid metabolism as well as lipodystrophy, leads to increased glucose consumption despite unaltered insulin levels, which ultimately results in reduced glucose concentrations in plasma and liver [16]. Here, INS is linked to lipodystrophy.